[The use of high dose intravenous immunoglobulins in dermatology].
High dose intravenous immunoglobulins (IVIG) are important agents in the treatment of numerous diseases in rheumatology and dermatology. Because the diseases treated with IVIG are rare, their use is mostly not based on controlled randomized trials. Since the high costs of therapy often prohibit the use of IVIG as first line therapy and as there are no guidelines on the use of IVIG in dermatologic diseases, a consensus conference was held in Wiesbaden, Germany, to address these issues. This manuscript documents the expert consensus on the use of IVIG in dermatology and reflects current clinical practice. It should be a guideline for the practitioner for the use of IVIG in dermatologic diseases.
Enk
Alexander
A
Univ. Hautkliniken Mainz. enk@hautklinik.klinik.uni-mainz.de
Hertl
Michael
M
Messer
Gerald
G
Meurer
Michael
M
Rentz
Ellen
E
Zillikens
Detlef
D
D003880:Dermatology / Q000379:methods* / Q000592:standards*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005858:Germany; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007275:Injections, Intravenous; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards*; D012871:Skin Diseases / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous